GlassScriptPhysician profile
Meredith M Schweitzer
NPI 1699861559
$37,460.11
in general payments reported to CMS, 2019-2025
64 companies · $5,364 in 2025
The $5,364 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,504 · 2020: $4,235 · 2021: $5,674 · 2022: $5,643 · 2023: $6,619 · 2024: $6,422 · 2025: $5,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,280.28 |
| Education | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $6,697.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $3,084.90 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $2,154.57 | 2019-2025 | Evenity, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $1,773.13 | 2021-2025 | |
| Abbvie INC. | $1,762.13 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,723.08 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,587.91 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,276.74 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,218.96 | 2019-2025 | Jardiance, Synjardy, Spiriva Respimat |
| Otsuka America Pharmaceutical, INC. | $1,067.94 | 2020-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,050.67 | 2022-2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $874.21 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $871.92 | 2019-2024 | Verquvo, Gardasil 9, Belsomra |
| Sanofi-Aventis U.S. LLC | $819.89 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $794.08 | 2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $746.22 | 2019-2025 | Trintellix |
| Gilead Sciences, INC. | $595.78 | 2019-2023 | |
| Astellas Pharma US INC | $585.35 | 2019-2025 | Veozah, Myrbetriq |
| Axsome Therapeutics, INC. | $577.48 | 2024-2025 | Auvelity, Symbravo |
| Janssen Pharmaceuticals, INC | $573.17 | 2019-2025 | Spravato |
| Biohaven Pharmaceuticals, INC. | $526.99 | 2021 | |
| Exact Sciences Corporation | $524.17 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $497.70 | 2020-2025 | Nexletol |
| Upsher-Smith Laboratories LLC | $468.21 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $461.61 | 2022-2024 | Gvoke Hypopen, Keveyis |
| Eisai INC. | $441.13 | 2020-2022 | |
| Beta Bionics, INC. | $407.73 | 2023-2024 | Ilet Bionic Pancreas |
| Shield Therapeutics INC | $406.48 | 2023-2025 | Accrufer |
| Zealand Pharma US, INC. | $383.10 | 2021-2022 | |
| Mannkind Corporation | $292.40 | 2024-2025 | |
| Insulet Corporation | $292.28 | 2022-2024 | Omnipod |
| Sumitomo Pharma America, INC. | $286.44 | 2023-2025 | Gemtesa |
| Allergan, INC. | $277.97 | 2019-2020 | |
| Amarin Pharma, INC. | $244.62 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $243.22 | 2019-2025 | Xifaxan, Trulance |
| Dexcom, INC. | $220.96 | 2020-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $177.48 | 2025 | Cequr Simplicity |
| Phathom Pharmaceuticals, INC. | $160.87 | 2024-2025 | Voquezna |
| Radius Health, INC. | $154.20 | 2019-2025 | Tymlos |
| Lundbeck LLC | $145.51 | 2024-2025 | Vyepti, Rexulti |
| Dynavax Technologies Corporation | $134.91 | 2023-2025 | Heplisav-B |
| Arbor Pharmaceuticals, INC. | $105.60 | 2021-2022 | |
| Optinose US, INC. | $99.20 | 2024-2025 | |
| Edwards Lifesciences Corporation | $95.45 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $89.62 | 2019-2023 | Seglentis, Livalo |
| Antares Pharma, INC. | $51.19 | 2019-2024 | Xyosted |
| Neurocrine Biosciences, INC. | $46.23 | 2025 | |
| Ascensia Diabetes Care US INC. | $43.78 | 2023 | |
| Impel Pharmaceuticals INC. | $40.60 | 2023 | Trudhesa |
| Inspire Medical Systems, INC. | $37.07 | 2024 | Inspire |
| Nevro Corp. | $27.98 | 2022-2024 | Senza |
| Valeritas, INC. | $26.32 | 2019 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Viiv Healthcare Company | $24.53 | 2022 | |
| Zyla Life Sciences, INC. | $23.81 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $17.87 | 2024 | |
| Horizon Therapeutics Plc | $16.73 | 2022 | |
| Corcept Therapeutics | $16.48 | 2023 | Korlym |
| Sunovion Pharmaceuticals INC. | $16.28 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $14.98 | 2020 | |
| Sanofi Pasteur INC. | $14.89 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.75 | 2023 | Edarbi |
| Daiichi Sankyo INC. | $14.53 | 2021 | |
| Vanda Pharmaceuticals INC. | $13.51 | 2024 | Hetlioz, Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Schweitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.